Skip to main content
Equibles

WELLINGTON MANAGEMENT GROUP LLP

Position in RDY — Dr Reddys Laboratories Ltd

CIK 902219 Boston, MA
Back to RDY Full portfolio

Position in RDY

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$1,198,482
-$1,163,994 QoQ
Shares Held
82,711
-51.5% QoQ
Ownership
0.010%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#76
of 238 holders
Holding Since
Mar 2020
23 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in RDY Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

WELLINGTON MANAGEMENT GROUP LLP holds $2,155,261,599 across 33 Drug Manufacturers - Specialty & Generic names. RDY ranks #26 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 UTHR
UNITED THERAPEUTICS Corp
 1,379,025 $747,197,111
2 ZTS
Zoetis Inc.
 9,423,895 $677,201,094
3 TEVA
Teva Pharmaceutical Industries Ltd
 7,671,157 $259,898,795
4 ALKS
Alkermes plc.
 2,814,804 $147,495,727
5 LNTH
Lantheus Holdings, Inc.
 1,013,063 $112,389,207
6 ELAN
Elanco Animal Health Inc
 2,676,050 $65,857,589
7 HLN
Haleon plc
 3,273,583 $30,542,527
8 XERS
Xeris Biopharma Holdings, Inc.
 2,365,103 $18,731,613

All Filings in RDY

Export CSV
23 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,198,482 82,711
2026-03-31 $2,362,476 170,576
2025-12-31 $1,688,225 120,244
2025-09-30 $1,681,010 120,244
2025-06-30 $10,519,029 699,869
2025-03-31 $8,547,911 648,060
2024-12-31 $14,150,445 896,165
2024-09-30 $13,387,325 168,500
2024-06-30 $13,304,069 174,617
2024-03-31 $10,887,193 148,428
2023-12-31 $10,050,483 144,445
2023-09-30 $9,438,967 141,154
2023-06-30 $6,331,763 100,329
2023-03-31 $2,968,500 52,143
2022-12-31 $2,107,777 40,730
2022-09-30 $1,174,038 22,431
2022-06-30 $1,242,453 22,431
2022-03-31 $1,250,079 22,431
2021-03-31 $5,952,558 96,963
2020-12-31 $20,184,835 283,137
2020-09-30 $22,956,258 330,021
2020-06-30 $19,925,556 375,883
2020-03-31 $20,054,495 497,260